Profile data is unavailable for this security.
About the company
VIVA Biotech Holdings is an investment holding company. The Company has two segments. The Drug Discovery Services segment provides structure-based drug discovery services to biotech and pharmaceutical clients for preclinical innovative drug development. The Contract Design and Manufacturing (CDMO) and Commercialization Services segment is engaged in contract development and manufacturing services for small molecule Active Pharmaceutical Ingredients (APIs) and intermediates, as well as the trading of APIs, intermediates and finished products. The Company conducts business primarily in the United States, China, Europe and other regions.
- Revenue in HKD (TTM)2.08bn
- Net income in HKD194.88m
- Incorporated2008
- Employees2.09k
- LocationVIVA Biotech Holdings735 Ziping RoadZhoupu Town, Pudong New DistrictShanghai 201318ChinaCHN
- Phone+86 2 160893288
- Fax+86 2 158243936
- Websitehttps://www.vivabiotech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jbm (Healthcare) Ltd | 812.98m | 216.39m | 2.24bn | 412.00 | 10.24 | 2.08 | 8.06 | 2.75 | 0.2657 | 0.2657 | 0.9984 | 1.31 | 0.5111 | 3.76 | 5.05 | 2,913,918.00 | 14.09 | 6.57 | 17.00 | 7.83 | 56.76 | 47.82 | 27.56 | 16.60 | 2.41 | -- | 0.2486 | 53.40 | 20.65 | 15.44 | 51.20 | 36.90 | 35.96 | -- |
| Essex Bio-Technology Ltd | 1.73bn | 313.18m | 2.27bn | 1.43k | 7.26 | 0.9975 | 6.12 | 1.31 | 0.5508 | 0.5508 | 3.05 | 4.01 | 0.5596 | 2.96 | 2.84 | 1,196,360.00 | 10.10 | 10.28 | 13.56 | 13.62 | 89.50 | 87.73 | 18.05 | 18.70 | 1.82 | -- | 0.1135 | 17.49 | -3.87 | 5.47 | 11.61 | 0.3101 | -7.47 | 7.14 |
| Golden Throat Holdings Group Co Ltd | 1.11bn | 303.26m | 2.27bn | 842.00 | 7.48 | 1.66 | 6.66 | 2.05 | 0.4102 | 0.4102 | 1.50 | 1.85 | 0.467 | 2.29 | 5.32 | 1,267,916.00 | 12.78 | 11.71 | 21.02 | 16.75 | 76.42 | 73.08 | 27.37 | 25.87 | 1.73 | 21.95 | 0.3616 | 94.67 | 23.26 | 8.25 | 27.37 | 13.71 | -12.27 | 34.38 |
| Jacobson Pharma Corporation Ltd | 1.53bn | 302.58m | 2.52bn | 1.79k | 8.29 | 1.13 | 5.58 | 1.64 | 0.1519 | 0.1519 | 0.7698 | 1.12 | 0.4299 | 2.54 | 9.06 | 876,757.00 | 8.48 | 4.83 | 10.29 | 6.17 | 44.30 | 41.26 | 19.73 | 14.85 | 0.9023 | 10.21 | 0.286 | 57.09 | 7.43 | 0.0691 | 43.09 | 7.05 | 24.09 | 14.87 |
| SinoMab Bioscience Ltd | 0.00 | -163.26m | 2.70bn | 61.00 | -- | 8.54 | -- | -- | -0.1508 | -0.1508 | 0.00 | 0.2285 | 0.00 | -- | -- | 0.00 | -18.46 | -22.26 | -24.62 | -25.68 | -- | -- | -- | -3,832.94 | -- | -7.82 | 0.6265 | -- | 48.42 | -- | 23.85 | -- | -0.376 | -- |
| AIM Vaccine Co Ltd | 1.43bn | -304.38m | 3.61bn | 1.49k | -- | 0.9651 | -- | 2.53 | -0.2503 | -0.2503 | 1.17 | 3.05 | 0.174 | 0.7724 | 1.12 | 930,316.90 | -3.71 | -8.04 | -6.66 | -12.31 | 71.80 | 79.64 | -21.32 | -39.38 | 0.5882 | -3.70 | 0.3341 | -- | 8.22 | 6.19 | 78.69 | -- | -7.20 | -- |
| VIVA Biotech Holdings | 2.08bn | 194.88m | 4.24bn | 2.09k | 28.11 | 0.9535 | 8.44 | 2.04 | 0.0708 | 0.0708 | 0.6807 | 2.09 | 0.2612 | 4.24 | 4.94 | 1,007,033.00 | 3.22 | -1.28 | 3.81 | -1.56 | 37.44 | 34.30 | 12.33 | -4.94 | 1.44 | -- | 0.2283 | -- | -7.84 | 43.80 | 244.08 | -8.85 | 27.82 | -- |
| Shandong Boan Biotechnology Co Ltd | 856.01m | 36.23m | 4.39bn | 714.00 | 111.08 | 1.76 | 33.34 | 5.13 | 0.0636 | 0.0636 | 1.51 | 4.00 | 0.2530 | 1.34 | 1.73 | 1,052,897.00 | 1.07 | -- | 1.41 | -- | 71.70 | -- | 4.23 | -- | 1.45 | 1.81 | 0.2827 | -- | 17.50 | -- | 161.31 | -- | -- | -- |
| Beijing Luzhu Biotechnology Co Ltd | 0.00 | -153.68m | 4.87bn | 197.00 | -- | 5.88 | -- | -- | -0.7657 | -0.7657 | 0.00 | 4.17 | 0.00 | -- | -- | 0.00 | -12.48 | -- | -13.69 | -- | -- | -- | -- | -- | 4.68 | -- | 0.2296 | -- | -- | -- | 32.53 | -- | -- | -- |
| Ocumension Therapeutics | 615.00m | -281.93m | 5.26bn | 505.00 | -- | 1.27 | -- | 8.55 | -0.3763 | -0.3763 | 0.8213 | 5.08 | 0.1571 | 4.30 | 3.35 | 1,257,675.00 | -7.20 | -24.03 | -7.62 | -25.71 | 42.58 | 58.38 | -45.84 | -400.90 | 4.86 | -- | 0.0223 | -- | 69.38 | 365.95 | 29.36 | -- | 213.01 | -- |
| Tong Ren Tang Technologies Co Ltd | 7.86bn | 488.31m | 5.32bn | 3.89k | 10.88 | 0.6441 | 4.30 | 0.6763 | 0.3813 | 0.3813 | 6.14 | 6.44 | 0.482 | 0.8615 | 6.00 | 1,969,182.00 | 5.47 | 7.44 | 8.57 | 12.07 | 39.82 | 42.21 | 11.34 | 15.10 | 2.79 | -- | 0.1913 | 39.34 | 7.18 | 10.15 | -11.59 | 4.55 | -8.30 | 3.37 |
Data as of Mar 05 2026. Currency figures normalised to VIVA Biotech Holdings's reporting currency: Hong Kong Dollar HKD
8.38%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Temasek Holdings Pte Ltd. (Investment Management)as of 31 Dec 2024 | 150.00m | 7.04% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 19.83m | 0.93% |
| SSgA Funds Management, Inc.as of 05 Feb 2026 | 4.58m | 0.22% |
| American Century Investment Management, Inc.as of 05 Feb 2026 | 2.48m | 0.12% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 1.23m | 0.06% |
| DFA Australia Ltd.as of 31 Jan 2026 | 333.87k | 0.02% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 0.00 | 0.00% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
